MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

205.61 -2.77 (-1.33%)
Streaming Delayed Price Updated: 10:38 AM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,426,549
Open 207.94
Bid (Size) 205.53 (100)
Ask (Size) 205.69 (100)
Prev. Close 208.38
Today's Range 203.43 - 208.33
52wk Range 168.54 - 244.81
Shares Outstanding N/A
Dividend Yield 3.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Best High-Yield Dividend Stocks to Buy for 2026 and Beyond ↗
These stocks pay juicy dividends but also offer much more. 
Via The Motley Fool
Topics Economy
News headline image
3 Stocks I Plan to Hold for the Next 20 Years ↗
These stocks are keepers. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property

Performance

YTD
-10.3%
-10.3%
1 Month
+0.3%
+0.3%
3 Month
-3.9%
-3.9%
6 Month
-11.4%
-11.4%
1 Year
+20.8%
+20.8%

More News

Read More
News headline image
The Psychedelic Revolution in Mental Healthcare ↗
Via The Motley Fool
News headline image
Why AbbVie Is a No-Brainer Stock to Buy on the Dip ↗
Via The Motley Fool
News headline image
1 Value Stock Worth Your Attention and 2 That Underwhelm
Via StockStory
News headline image
3 High-Yielding Dividend Stocks to Buy, Even If You're Worried About the Market ↗
Via The Motley Fool
News headline image
Could AbbVie Crash Lilly's Weight‑Loss Party? ↗
Via The Motley Fool
News headline image
The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
This Indicator Has Called Every Recession Over the Last 80 Years. Here's What It's Saying Now. ↗
Via The Motley Fool
Topics Economy
News headline image
2 S&P 500 Stocks with Solid Fundamentals and 1 We Brush Off
Via StockStory
Topics Stocks
News headline image
The Science of Scale: An In-Depth Look at Regeneron Pharmaceuticals (REGN) in 2026
Via Finterra
Topics Earnings Economy Intellectual Property
News headline image
S&P 500 Index Dividend Yields Are Teasing All-Time Lows. Here Are 3 Dividend Darlings That Crush This Trend. ↗
Via The Motley Fool
Topics Stocks
News headline image
3 Market-Beating Stocks with Competitive Advantages
Via StockStory
News headline image
Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis
Via MarketMinute
Topics Bonds
News headline image
3 Dividend Aristocrats Whose Yields Can Help Combat Inflation ↗
Via MarketBeat
Topics Economy
News headline image
3 Companies Aggressively Raising Dividends While Others Play Defense ↗
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
This Investor's $5 Million ETF Buy Pushes 2028 Bond Fund to Nearly 4% of AUM ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
This Fund's Ladder Strategy Expanded With a $4 Million Buy in One 2027 Bond ETF ↗
Via The Motley Fool
Topics Bonds ETFs
News headline image
Red Spruce Adds $3.35 Million to a 2029 Bond ETF With 4.5% Yield. Here's What Investors Should Know ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
1 Healthcare Stock on Our Watchlist and 2 We Avoid
Via StockStory
News headline image
3 Absurdly Cheap Dividend Stocks to Buy in April 2026 ↗
Via The Motley Fool
Topics Economy
News headline image
This Pharma Dividend Has Been Raised Every Single Year for Over a Decade ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy AbbVie Stock Before April 29? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
Via MarketMinute
Topics Economy World Trade
News headline image
Regeneron Pharmaceuticals: The Scientific Juggernaut Navigating a High-Stakes Transformation
Via Finterra
Topics Economy Intellectual Property World Trade

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 205.61
When was AbbVie last traded?
The last trade of AbbVie was at 04/20/26 10:38 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story